Login to Your Account



Search

Search results

Pharma: Clinic roundup

Abbvie Inc. , of North Chicago, initiated a global phase III trial evaluating the safety and efficacy of veliparib (ABT-888) in patients with previously untreated locally advanced or metastatic squamous non-small-cell lung cancer (NSCLC). (B ...

BioWorld Today - Staff - 2014-04-16 00:00 - 0 comments - 0 attachments

Clinic roundup

Intercept Pharmaceuticals Inc. , of New York, presented results from the phase III POISE trial of obeticholic acid (OCA) for the treatment of primary biliary cirrhosis (PBC) at the International Liver Congress of the European Association of the Study ...

BioWorld Today - Staff - 2014-04-15 00:00 - 0 comments - 0 attachments

Clinic roundup

Dendreon Corp. , of Seattle, reported that preliminary data from a long-term analysis of the phase II STAND study suggested tumor-specific T-cell responses appear to be enhanced and sustained when Provenge (sipuleucel-T) is given following androgen d ...

BioWorld Today - Staff - 2014-04-14 00:00 - 0 comments - 0 attachments

Clinic Roundup

• TapImmune Inc. , of Seattle, said an interim safety analysis of the first five breast cancer patients treated with HER2/neu Class II antigens did not show any serious adverse events, so treatment of the remaining 17 patients in the Phase I st ...

BioWorld Today - Staff - 2013-01-10 01:00 - 0 comments - 0 attachments

Clinic roundup

Affimed Therapeutics AG , of Heidelberg, Germany, said results from a phase I trial of AFM13, its monotherapy for the treatment of patients with advanced relapsing/refractory Hodgkin lymphoma, confirmed the drug's safety in 28 heavily pretreated pati ...

BioWorld Today - Staff - 2014-04-11 00:00 - 0 comments - 0 attachments

Clinic roundup

Aegerion Pharmaceuticals Inc. , of Cambridge, Mass., said patient enrollment was initiated in Japan in a phase III trial of lomitapide as an adjunct treatment to reduce low-density lipoprotein cholesterol (LDL-C) in Japanese patients with homozygous ...

BioWorld Today - Staff - 2014-04-10 00:00 - 0 comments - 0 attachments

Clinic roundup

Oncolytics Biotech Inc. , of Calgary, Alberta, reported additional data from its phase III REO 018 study testing Reolysin in combination with carboplatin and paclitaxel in patients with second-line, platinum-refractory, taxane-naïve head and nec ...

BioWorld Today - Staff - 2014-04-09 00:00 - 0 comments - 0 attachments

Clinic roundup

Pacira Pharmaceuticals Inc. announced additional phase III data supporting the safety and efficacy of (bupivacaine liposome injectable suspension) to achieve a femoral nerve block in patients undergoing total knee arthroplasty. (BioWorld-To ...

BioWorld Today - Staff - 2014-04-08 00:00 - 0 comments - 0 attachments

Clinic roundup

Noxxon Pharma AG , of Berlin, said phase IIa proof-of-concept data from the emapticap pegol (NOX-E36) trial in diabetic nephropathy were presented at the ISN Nexus Symposium in Bergamo, Italy. (BioWorld-Today-2014-04-07) ...

BioWorld Today - Staff - 2014-04-07 00:00 - 0 comments - 0 attachments

Clinic Roundup

No Abstract (BioWorld Today, BioWorld-Today-2007-12-31) ...

BioWorld Today - Staff - 2007-12-31 01:00 - 0 comments - 0 attachments